IGI LABS INC FDA Approval ANDA 075263

ANDA 075263

IGI LABS INC

FDA Drug Application

Application #075263

Documents

Letter2000-06-26

Application Sponsors

ANDA 075263IGI LABS INC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 5MG BASE/ML0MIDAZOLAM HYDROCHLORIDEMIDAZOLAM HYDROCHLORIDE

FDA Submissions

ORIG1TA1999-11-08

Submissions Property Types

ORIG1Null0

CDER Filings

IGI LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75263
            [companyName] => IGI LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIDAZOLAM HYDROCHLORIDE","activeIngredients":"MIDAZOLAM HYDROCHLORIDE","strength":"EQ 5MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MIDAZOLAM HYDROCHLORIDE","submission":"MIDAZOLAM HYDROCHLORIDE","actionType":"EQ 5MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.